Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-25 09:32 am Purchase | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 2,050,000 5.450% | 2,050,000 (New Position) | Filing History |
| 2022-08-19 4:34 pm Purchase | 2022-08-17 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 9,192,814 19.990% | 5,732,463 (+165.66%) | Filing History |
| 2022-06-21 10:04 am Purchase | 2022-06-16 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 15,230,473 19.990% | 15,230,473 (New Position) | Filing History |
| 2022-04-21 10:00 am Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 3,759,510 9.900% | 3,759,510 (New Position) | Filing History |
| 2022-04-21 10:00 am Purchase | 2022-04-11 | 13G | Annexon, Inc. ANNX | Fairmount Funds Management LLC | 2,569,400 6.700% | 2,569,400 (New Position) | Filing History |
| 2022-02-11 1:26 pm Purchase | 2022-02-04 | 13G | Olema Pharmaceuticals, Inc. OLMA | Fairmount Funds Management LLC | 2,107,873 5.200% | 2,107,873 (New Position) | Filing History |
| 2022-02-08 4:31 pm Sale | 2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 911,736 7.000% | -62,869 (-6.45%) | Filing History |
| 2021-09-23 4:31 pm Purchase | 2021-09-21 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 3,460,351 19.990% | 3,460,351 (New Position) | Filing History |
| 2021-09-22 3:57 pm Purchase | 2021-09-20 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 974,605 7.600% | 974,605 (New Position) | Filing History |
| 2021-06-17 1:32 pm Purchase | 2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 682,028 5.300% | 682,028 (New Position) | Filing History |
| 2021-01-05 06:04 am Purchase | 2021-12-31 | 13D | MIRAGEN THERAPEUTICS INC MGEN | Fairmount Funds Management LLC | 967,671 19.990% | 967,671 (New Position) | Filing History |